2VX0
ephB4 kinase domain inhibitor complex
Summary for 2VX0
Entry DOI | 10.2210/pdb2vx0/pdb |
Related | 2BBA 2VWU 2VWV 2VWW 2VWX 2VWY 2VWZ 2VX1 |
Descriptor | EPHRIN TYPE-B RECEPTOR 4, N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE, MAGNESIUM ION, ... (4 entities in total) |
Functional Keywords | mutant, membrane, transferase, atp-binding, polymorphism, glycoprotein, transmembrane, phosphoprotein, unphosphorylated, nucleotide-binding |
Biological source | HOMO SAPIENS (HUMAN) |
Total number of polymer chains | 1 |
Total formula weight | 34433.60 |
Authors | Read, J.,Brassington, C.A.,Green, I.,McCall, E.J.,Valentine, A.L.,Barratt, D.,Leach, A.G.,Kettle, J.G. (deposition date: 2008-06-30, release date: 2008-10-28, Last modification date: 2023-12-13) |
Primary citation | Bardelle, C.,Cross, D.,Davenport, S.,Kettle, J.G.,Ko, E.J.,Leach, A.G.,Mortlock, A.,Read, J.,Roberts, N.J.,Robins, P.,Williams, E.J. Inhibitors of the Tyrosine Kinase Ephb4. Part 1: Structure-Based Design and Optimization of a Series of 2,4-Bis-Anilinopyrimidines. Bioorg.Med.Chem.Lett., 18:2776-, 2008 Cited by PubMed: 18434142DOI: 10.1016/J.BMCL.2008.04.015 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report